DrugDashboards

metoprolol succinate

metoprolol succinate · METOPROLOL SUCCINATE 25 mg/1 · Tablet, Film Coated, Extended Release · Oral · Actavis Pharma, Inc.

NDC 45963-0709-96 · 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply. The price is down 17% over the past year, to $0.0498 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0498per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.1825per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$0.1438per unitAvKare, LLC · Jun 15, 2023289% of what pharmacies pay — higher than 81% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$0.0548per TABweighted avg manufacturer price $0.0313 · Aug 1, 2026110% of what pharmacies pay — higher than 62% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00$30.00Nov 2019Sep 2026$0.0498
83 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$1.50
#90 count
$4.49

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$1.1M
88,588 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • manufacturer plans to discontinue+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for metoprolol succinate (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA204161
TE code
AB
Approval date
Nov 25, 2016
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11)Aug 31, 2026
  • Planned discontinuation — Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96)Aug 31, 2026
  • Planned discontinuation — Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11)Aug 31, 2026
  • Planned discontinuation — Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11)Aug 31, 2026
  • Planned discontinuation — Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96)Aug 31, 2026
  • Planned discontinuation — Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11)Aug 31, 2026
  • Planned discontinuation — Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96)Aug 31, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of metoprolol succinate (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 3, 2026
Northwind Health Company, LLCMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.METOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.METOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.METOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingMETOPROLOL SUCCINATE 100 mg/1Aug 12, 2026Sep 2, 2026
American Health PackagingMETOPROLOL SUCCINATE 25 mg/1Aug 12, 2026Sep 2, 2026
American Health PackagingMETOPROLOL SUCCINATE 50 mg/1Aug 12, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
AvPAKMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
AvPAKMETOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
AvPAKMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
AvPAKMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.METOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.METOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.METOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.METOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncMETOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedMETOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
Granules Pharmaceuticals Inc.METOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Granules Pharmaceuticals Inc.METOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Granules Pharmaceuticals Inc.METOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Granules Pharmaceuticals Inc.METOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "metoprolol succinate — NDC 45963-0709-96," retrieved September 3, 2026, https://drugdashboards.com/drug/45963070996.

Free to cite with attribution — see how the data is put together.